1887
Preview this article:
Zoom in
Zoomout

Carbapenems: do they have a future?, Page 1 of 1

| /docserver/preview/fulltext/jmm/60/9/1229_jmm031013-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.031013-0
2011-09-01
2019-12-06
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/9/1229.html?itemId=/content/journal/jmm/10.1099/jmm.0.031013-0&mimeType=html&fmt=ahah

References

  1. Amyes S. G. B. , Walsh F. M. , Bradley J. S. . ( 2007; ). Best in class: a good principle for antibiotic usage to limit resistance development?. J Antimicrob Chemother 59:, 825–826. [CrossRef].[PubMed]
    [Google Scholar]
  2. Brown S. , Amyes S. G. B. . ( 2006; ). OXA (β)-lactamases in Acinetobacter: the story so far. . J Antimicrob Chemother 57:, 1–3. [CrossRef].[PubMed]
    [Google Scholar]
  3. Doumith M. , Ellington M. J. , Livermore D. M. , Woodford N. . ( 2009; ). Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. . J Antimicrob Chemother 63:, 659–667. [CrossRef].[PubMed]
    [Google Scholar]
  4. Edwards J. R. . ( 1995; ). Meropenem: a microbiological overview. . J Antimicrob Chemother 36: (Suppl. A), 1–17.[PubMed] [CrossRef]
    [Google Scholar]
  5. Gehrlein M. , Leying H. , Cullmann W. , Wendt S. , Opferkuch W. . ( 1991; ). Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins. . Chemotherapy 37:, 405–412. [CrossRef].[PubMed]
    [Google Scholar]
  6. Girlich D. , Poirel L. , Nordmann P. . ( 2009; ). CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli . . Antimicrob Agents Chemother 53:, 832–834. [CrossRef].[PubMed]
    [Google Scholar]
  7. Jacoby G. A. , Mills D. M. , Chow N. . ( 2004; ). Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumoniae . . Antimicrob Agents Chemother 48:, 3203–3206. [CrossRef].[PubMed]
    [Google Scholar]
  8. Kahan F. M. , Kropp H. , Sundelof J. G. , Birnbaum J. . ( 1983; ). Thienamycin: development of imipenen-cilastatin. . J Antimicrob Chemother 12: (Suppl. D), 1–35.[PubMed] [CrossRef]
    [Google Scholar]
  9. Kumarasamy K. K. , Toleman M. A. , Walsh T. R. , Bagaria J. , Butt F. , Balakrishnan R. , Chaudhary U. , Doumith M. , Giske C. G. et al. ( 2010; ). Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. . Lancet Infect Dis 10:, 597–602. [CrossRef].[PubMed]
    [Google Scholar]
  10. Li J. , Nation R. L. , Turnidge J. D. , Milne R. W. , Coulthard K. , Rayner C. R. , Paterson D. L. . ( 2006; ). Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. . Lancet Infect Dis 6:, 589–601. [CrossRef].[PubMed]
    [Google Scholar]
  11. Livermore D. M. , Sefton A. M. , Scott G. M. . ( 2003; ). Properties and potential of ertapenem. . J Antimicrob Chemother 52:, 331–344. [CrossRef].[PubMed]
    [Google Scholar]
  12. Peleg A. Y. , Seifert H. , Paterson D. L. . ( 2008; ). Acinetobacter baumannii: emergence of a successful pathogen. . Clin Microbiol Rev 21:, 538–582. [CrossRef].[PubMed]
    [Google Scholar]
  13. Poirel L. , Nordmann P. . ( 2002; ). Acquired carbapenem-hydrolyzing β-lactamases and their genetic support. . Curr Pharm Biotechnol 3:, 117–127. [CrossRef].[PubMed]
    [Google Scholar]
  14. Poirel L. , Nordmann P. . ( 2006; ). Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene bla OXA-58 in Acinetobacter baumannii . . Antimicrob Agents Chemother 50:, 1442–1448. [CrossRef].[PubMed]
    [Google Scholar]
  15. Turton J. F. , Ward M. E. , Woodford N. , Kaufmann M. E. , Pike R. , Livermore D. M. , Pitt T. L. . ( 2006; ). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii . . FEMS Microbiol Lett 258:, 72–77. [CrossRef].[PubMed]
    [Google Scholar]
  16. Walsh T. R. , Toleman M. A. , Poirel L. , Nordmann P. . ( 2005; ). Metallo-β-lactamases: the quiet before the storm?. Clin Microbiol Rev 18:, 306–325. [CrossRef].[PubMed]
    [Google Scholar]
  17. Wiseman L. R. , Wagstaff A. J. , Brogden R. N. , Bryson H. M. . ( 1995; ). Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. . Drugs 50:, 73–101. [CrossRef].[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.031013-0
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error